POSC108 Estimated Hospitalization-Related Costs with Oral Azacitidine (ORAL-AZA) vs. Placebo for Remission Maintenance in Patients with Acute Myeloid Leukemia (AML) in Sweden and Norway
Abstract
Authors
K Porkka E Oliva B Skikne C Beach J Zhong S Ranjan R Potluri H Jalan C Chen